High expression of tenascin-C correlates with cancer grade and poor prognosis in various cancers [245], including esophageal squamous cell carcinoma [246], glioma [247], gastric [248], prostate [249], breast [250] and colorectal cancer [251,252,253]. This evidence concerns the gene TNC and glioma.